The importance of cultural tailoring of communicators and media outlets in an influenza vaccination awareness campaign: a digital randomized trial.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
16 02 2023
16 02 2023
Historique:
received:
21
07
2022
accepted:
10
01
2023
entrez:
16
2
2023
pubmed:
17
2
2023
medline:
22
2
2023
Statut:
epublish
Résumé
The COVID-19 pandemic has exposed the vulnerability of ethnic minorities again. Health inequity within ethnic minorities has been explained by factors such as higher prevalence of underlying disease, restricted access to care, and lower vaccination rates. In this study, we investigated the effect of cultural tailoring of communicators and media outlets, respectively, on vaccine willingness in an influenza vaccination campaign in the Netherlands. A total of 1226 participants were recruited from two culturally non-tailored media outlets (Dutch newspaper and Facebook), and one media outlet tailored to a large community in the Netherlands with Indian ancestry. The participants from all three media outlets were randomly exposed to a vaccination awareness video delivered by a physician with an Indian or Dutch background, followed by an online survey. Cultural tailoring compared to cultural non-tailoring of communicators showed no difference in improvement of vaccine willingness (13.9% vs. 20.7% increment, respectively, p = 0.083). However, the media outlet tailored to the community with Indian ancestry, resulted in a higher improvement of vaccine willingness compared to non-tailored media outlets (46.7% vs. 14.7% increment, respectively, p < 0.001, unadjusted OR = 5.096). These results suggest that cultural tailoring of media outlets may be critical to effectively reach out to ethnic minorities to help optimize vaccination rates and improve general health.
Identifiants
pubmed: 36797274
doi: 10.1038/s41598-023-27910-y
pii: 10.1038/s41598-023-27910-y
pmc: PMC9935604
doi:
Substances chimiques
Influenza Vaccines
0
Types de publication
Randomized Controlled Trial
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1744Informations de copyright
© 2023. The Author(s).
Références
Heart. 2015 Nov;101(21):1738-47
pubmed: 26310262
JAMA Netw Open. 2021 Dec 1;4(12):e2140529
pubmed: 34967887
J Health Commun. 2014;19(3):321-39
pubmed: 24117390
Ann Intern Med. 2021 Apr;174(4):484-492
pubmed: 33347320
JAMA Netw Open. 2020 Jul 1;3(7):e2014323
pubmed: 32639569
Vaccine. 2017 Feb 22;35(8):1167-1174
pubmed: 28126202
EClinicalMedicine. 2021 May 15;35:100881
pubmed: 34124631
JAMA. 2020 Jun 23;323(24):2466-2467
pubmed: 32391864
Neth Heart J. 2021 Nov;29(11):545-550
pubmed: 34648125
Vaccine. 2021 Jun 23;39(28):3678-3695
pubmed: 34090700
JAMA Netw Open. 2020 Jun 1;3(6):e2012403
pubmed: 32556260
Nat Med. 2022 Mar;28(3):460-467
pubmed: 35273402
Nature. 2022 Jan;601(7891):18-20
pubmed: 34983989
N Engl J Med. 2021 Jul 8;385(2):97-100
pubmed: 33789007
PLoS One. 2012;7(4):e34054
pubmed: 22506011
N Engl J Med. 2021 Dec 23;385(26):2403-2406
pubmed: 34919356
Vaccine. 2018 Aug 23;36(35):5273-5281
pubmed: 30061026